June 14, 2022
Social

Tokyo, Japan (June 14, 2022) – Daiichi Sankyo Company, Limited today announced that its affiliate, the Japan Research Foundation for Clinical Pharmacology* (headquarters, Tokyo; Director General, Toshiaki Sai), has awarded its 15th “Japan Research Foundation for Clinical Pharmacology Research Award” to five young researchers.


Award recipients are selected from research papers submitted from projects funded with subsidies from the foundation, and innovative research projects with expectations for future development are eligible for the award.


The Foundation hopes that this award will motivate young clinical pharmacology researchers who are involved in the establishment of appropriate drug treatments and encourage future research results. The awards ceremony and presentation of research themes will be held on November 15, 2022.


*The mission of the Foundation is to promote clinical pharmacology and foster the development of clinical pharmacologists. The Foundation was established in 1975 and has worked on a variety of projects relating to clinical pharmacology, including promotion of research and overseas studies for Japanese researchers.

Recipients of the 15th Japan Research Foundation for Clinical Pharmacology Research Award

 

Recipient

Organization

Research theme

Yu Imamura

Esophageal Surgery,
Gastroenterological Surgery,
Cancer Institute Hospital

Immunogenic characteristics of low-level microsatellite instability (MSI-L) in esophagogastric junction adenocarcinoma

Yoshiaki Okada

Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmaceutical Sciences
Osaka University

Development of new anti-inflammatory drugs targeting vascular permeability

Aiko Ogawa

Division of Molecular and Cellular Medicine, Department of Clinical Science
National Hospital Organization Okayama Medical Center

Fabrication of 3D in vitro model of vascular medial thickening in pulmonary arterial hypertension

Eiko Nagata

Department of Pediatrics,
Hamamatsu University School of Medicine

Efficacy and safety of propranolol cream in infantile hemangioma: An open-label single-arm clinical trial

Hiroyuki Nakamura

Laboratory of Chemical Pharmacology
Graduate School of Pharmaceutical Sciences
Chiba University

Elucidation of the pathophysiology and development of a novel therapeutic agent of Niemann-Pick disease type C
Back to index